Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis

陈春林, 刘萍, 曾北蓝, 马奔, Hao Zhang
In: Chin J Obstet Gynecol · 2006 · vol. 41(10) , pp. 660–663 · doi:10.3760/j.issn:0529-567x.2006.10.004 · W3030411052
Non-randomised trial OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-01 ⓘ

Uterine artery embolization (UAE) effectively treated dysmenorrhea in 82.4% and normalized excessive menstrual bleeding in 78 out of 93 patients, demonstrating good mid-to-long term efficacy for adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-09 · read from full text ⓘ

This study evaluated the intermediate and long-term clinical efficacy of uterine artery embolization in 189 patients diagnosed with adenomyosis. Researchers monitored changes in dysmenorrhea and menstrual volume over a mean follow-up period of 50 months, finding that 82.4% of patients with preoperative pain experienced clinical improvement. The treatment resulted in normal menstrual flow for most women, although nine patients eventually required hysterectomy due to ineffective or recurrent symptoms. This paper is centrally about adenomyosis — specifically evaluating the mid-to-long term outcomes of uterine artery embolization as a therapeutic intervention for the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

目的 探讨子宫动脉栓塞术(UAE)治疗子宫腺肌病(AM)的中远期疗效.方法对189例AM患者行UAE治疗,术前1个月及术后1、2、3、6、12、18个月及以后每年1次随访观察痛经、月经量的变化.结果 (1)随访情况:UAE术后具有完整随访资料者168例,随访率88.9%,平均随访时间(50±15)个月.9例患者因痛经治疗无效或复发等原因而切除子宫.(2)痛经症状的变化:168例患者中,159例术前有痛经症状,UAE治疗后131例(82.4%,131/159)为临床有效,28例(17.6%,28/159)为临床无效,8例(5.0%,8/159)复发.AM合并和未合并子宫肌瘤患者的痛经临床有效率分别为92.9%(39/42)、78.6%(92/117),两者比较,差异无统计学意义(P＞0.05);局灶型和弥漫型AM患者的痛经临床有效率分别为82.4%(75/91)、82.4%(56/68),两者比较,差异无统计学意义(P＞0.05).(3)月经量的变化:在168例患者中,93例为月经量过多,UAE术后78例月经量恢复正常,10例出现月经量过少,1例出现暂时性闭经,2例月经量无变化,2例出现月经稀少;74例为月经量正常,术后57例月经量无变化,15例出现月经量过少,2例出现子宫性闭经;1例为月经量过少的患者,术后月经量恢复正常.结论 UAE治疗AM具有较好的中远期疗效。
Full text 786 characters · extracted from oa-doi-fallback · click to expand
子宫动脉栓塞术治疗子宫腺肌病的中远期临床疗效观察 Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis 摘要目的 探讨子宫动脉栓塞术(UAE)治疗子宫腺肌病(AM)的中远期疗效.方法对189例AM患者行UAE治疗,术前1个月及术后1、2、3、6、12、18个月及以后每年1次随访观察痛经、月经量的变化.结果 (1)随访情况:UAE术后具有完整随访资料者168例,随访率88.9%,平均随访时间(50±15)个月.9例患者因痛经治疗无效或复发等原因而切除子宫.(2)痛经症状的变化:168例患者中,159例术前有痛经症状,UAE治疗后131例(82.4%,131/159)为临床有效,28例(17.6%,28/159)为临床无效,8例(5.0%,8/159)复发.AM合并和未合并子宫肌瘤患者的痛经临床有效率分别为92.9%(39/42)、78.6%(92/117),两者比较,差异无统计学意义(P＞0.05);局灶型和弥漫型AM患者的痛经临床有效率分别为82.4%(75/91)、82.4%(56/68),两者比较,差异无统计学意义(P＞0.05).(3)月经量的变化:在168例患者中,93例为月经量过多,UAE术后78例月经量恢复正常,10例出现月经量过少,1例出现暂时性闭经,2例月经量无变化,2例出现月经稀少;74例为月经量正常,术后57例月经量无变化,15例出现月经量过少,2例出现子宫性闭经;1例为月经量过少的患者,术后月经量恢复正常.结论 UAE治疗AM具有较好的中远期疗效. 更多相关知识 - 浏览653 - 被引88 - 下载227 相似文献 - 中文期刊 - 外文期刊 - 学位论文 - 会议论文

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK